Cooper Companies Inc.

NASDAQ: COO · Real-Time Price · USD
68.26
-11.70 (-14.63%)
At close: May 30, 2025, 3:59 PM
68.60
0.50%
After-hours: May 30, 2025, 05:57 PM EDT

Cooper Companies Revenue Breakdown

Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021 Oct 31, 2020 Oct 31, 2019 Oct 31, 2016 Oct 31, 2015 Oct 31, 2014 Oct 31, 2013 Oct 31, 2012
Coopersurgical Segment Revenue 1.29B 1.17B 1.07B 770.5M 587.9M 680.5M 389.6M 309.3M 325.13M 319.41M 255.89M
Coopersurgical Segment Revenue Growth +9.96% +9.80% +38.23% +31.06% -13.61% +74.67% +25.96% -4.87% +1.79% +24.82% n/a
Coopervision Segment Revenue 2.61B 2.42B 2.24B 2.15B 1.84B 1.97B 1.58B 1.49B 1.39B 1.27B 1.19B
Coopervision Segment Revenue Growth +7.66% +8.04% +4.24% +16.77% -6.58% +25.09% +6.01% +6.83% +9.80% +6.65% n/a

Revenue by Geography

Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021 Oct 31, 2020 Oct 31, 2019 Oct 31, 2018 Oct 31, 2017 Oct 31, 2016 Oct 31, 2015 Oct 31, 2014 Oct 31, 2013 Oct 31, 2012
Europe Revenue 2.22B 2.06B 1.88B 1.77B 1.12B 1.16B 1.25B 1.19B 1.15B 1.14B 928.43M 805.48M 727.01M
Europe Revenue Growth +7.93% +9.20% +6.29% +58.74% -3.35% -7.82% +5.64% +3.62% +0.42% +22.83% +15.26% +10.79% n/a
United States Revenue 2.57B 2.38B 2.15B 1.83B 1.5B n/a 1.44B 1.19B 1.14B 1.06B 1B 972.6M 879.35M
United States Revenue Growth +8.15% +10.33% +17.38% +22.66% n/a n/a +21.04% +4.00% +7.47% +5.73% +3.27% +10.60% n/a

Operating Expense Breakdown

Period Ending Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020 Apr 30, 2020 Jan 31, 2020 Oct 31, 2019 Jul 31, 2019 Apr 30, 2019 Jan 31, 2019 Oct 31, 2018 Jul 31, 2018 Apr 30, 2018 Jan 31, 2018 Oct 31, 2017 Jul 31, 2017 Apr 30, 2017 Jan 31, 2017 Oct 31, 2016 Jul 31, 2016 Apr 30, 2016 Jan 31, 2016 Oct 31, 2015 Jul 31, 2015 Apr 30, 2015 Jan 31, 2015
Selling, General, and Administrative Revenue 387.9M 391.4M 381.1M 380.3M 380.9M 387.6M 375.2M 407.5M 330.9M 358M 342.7M 322.4M 319.1M 311.6M 352.5M 285.8M 261.2M 264.2M 232.8M 237.2M 258.3M 250M 249.8M 246.8M 250M 248.6M 251M 247.9M 225.9M 208.5M 208.7M 193.3M 188.6M 189.13M 182.4M 177.66M 173.6M 179.64M 191.78M 167.58M 173.53M
Selling, General, and Administrative Revenue Growth -0.89% +2.70% +0.21% -0.16% -1.73% +3.30% -7.93% +23.15% -7.57% +4.46% +6.30% +1.03% +2.41% -11.60% +23.34% +9.42% -1.14% +13.49% -1.85% -8.17% +3.32% +0.08% +1.22% -1.28% +0.56% -0.96% +1.25% +9.74% +8.35% -0.10% +7.97% +2.49% -0.28% +3.69% +2.67% +2.34% -3.36% -6.33% +14.44% -3.43% n/a
Research and Development Revenue 40.7M 37.7M 39M 38.9M 39.5M 36.7M 36.5M 32.6M 31.6M 29.1M 28.7M 26.3M 26.2M 25.6M 24.8M 21M 21.4M 25.5M 21.8M 23.8M 22.2M 23.3M 21.5M 21M 21M 22.5M 22.5M 20.8M 18.8M 18.5M 17.5M 16.8M 16.3M 17.94M 16.01M 16.7M 14.76M 18.36M 18.3M 16.82M 16.11M
Research and Development Revenue Growth +7.96% -3.33% +0.26% -1.52% +7.63% +0.55% +11.96% +3.16% +8.59% +1.39% +9.13% +0.38% +2.34% +3.23% +18.10% -1.87% -16.08% +16.97% -8.40% +7.21% -4.72% +8.37% +2.38% 0.00% -6.67% 0.00% +8.17% +10.64% +1.62% +5.71% +4.17% +3.07% -9.15% +12.04% -4.09% +13.11% -19.60% +0.34% +8.79% +4.38% n/a